Presence and treatment of vascular risk factors in patients with vascular cognitive impairment

Archives of Neurology

Volumn 54, Issue 1, 1997, Pages 33-39

  Rockwood, Kenneth ^a,d   Ebly, Erika ^b   Hachinshi, Vladimir ^c   Hogan, David ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0031038589     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550130019010     Document Type: Article

References (49)

1. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645-648.
2. Erkinjuntti T, Hachinski V. Rethinking vascular dementia. Cerebrovasc Dis. 1993;3:3-23.
3. Hachinski V. Vascular dementia: a radical redefinition. Dementia. 1994;5:130- 132.
4. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473-480.
5. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia - diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
6. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and postmortem neuropathological study. J Neurol Neurosurg Psychiatry. 1988;51:1037-1044.
7. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992:25-31.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:143-146.
9. Roth M, Huppert FA, Tym E, Mountjoy CQ, eds. CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. Cambridge, Mass: Cambridge University Press; 1988.
10. Rockwood K, Parhad I, Hachinski V, et al. Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement. Can J Neurol Sci. 1994;21:358-364.
11. Starr JM, Whalley LJ. Senile hypertension and cognitive impairment: an overview. J Hypertens. 1992;10(suppl):31-42.
12. Meyer JS, Judd BW, Tawakina T, et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA. 1986;256:2203-2209.
13. Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. J Am Geriatr Soc. 1989;37:549-555.
14. Cebul RD. Aspirin and MID. J Am Geriatr Soc. 1989;37:573-575.
15. Meyer JS, Muramatsu K, Mortel KF, et al. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke. 1995;26:735-742.
16. Hogan DB, Ebly EM, Fung TS. Regional variations in the use of potentially inappropriate medications by Canadian seniors participating in the Canadian Study of Health and Aging. Can J Clin Pharmacol. 1995;2:167-174.
17. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med. 1996;124:292-298.
18. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J. 1994;150:899-913.
19. Graham JE, Rockwood K, Beattie BL, et al. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology. 1996;15:246-256.
20. Ebly E, Hogan D, Parhad I. Cognitive impairment in the nondemented elderly. Arch Neurol. 1995;52:612-619.
21. Canadian Study of Health and Aging. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology. 1994;44:2073- 2080.
22. Teng EL, Chui HC. The modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987:133-136.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
25. Tuokko H, Kristjansson E, Miller J. The neuropsychological detection of dementia: an overview of the neuropsychological tests fielded in the Canadian Study of Health and Aging. J Clin Exp Neuropsychol. 1995;17:352-373.
26. Hachinski VC, Iloff L, Zilkha K, et al. Multi-infarct dementia. Arch Neurol. 1975;32:632-637.
27. Scheinberg P. Dementia due to vascular disease: a multifactorial disorder. Stroke. 1988;19:1291-1299.
28. Applegate WB. High blood pressure treatment in the elderly. Clin Geriatr Med. 1992;8:103-118.
29. LaCroix AZ, Omenn GS. Older adults and smoking. Clin Geriatr Med. 1992;8:69-88.
30. Dalen JE, Goldberg RJ. Prophylactic aspirin and the elderly population. Clin Geriatr Med. 1992;8:119-126.
31. Roos NP, Shapiro E. The Manitoba longitudinal study on aging: preliminary findings on health care utilization by the elderly. Med Care. 1981;19:644-657.
32. Marshall VW. Factors affecting response and completion rates in some Canadian studies. Can J Aging. 1987;6:217-227.
33. Rockwood K, Stolee P, Robertson D, Shillington ER. Response bias in a health status survey of elderly people. Age Ageing. 1989;18:177-182.
34. Skoog I, Nilsson L, Palmertz B, Andreasson L, Svanborg A. A population- based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153-158.
35. Hébert R, Bravo G, Korner-Bitensky N, Vogen L. Refusal and information bias associated with postal questionnaires in very elderly subjects. J Clin Epidemiol. 1996;49:373-381.
36. Rockwood K, Tripp DA, Stadnyk K, Fisk J. Screening for cognitive impairment in the elderly: impact of physical function measures added to cognitive screening instruments. Aging Cognition. 1994;1:261-270.
37. Grace J, Nadler JD, White DA, et al. Folstein vs modified Mini-Mental State Examination in geriatric stroke: stability, validity, and screening utility. Arch Neurol. 1995;52:477-484.
38. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. JAMA. 1995;274:1846-1851.
39. Ferruci L, Guralnick JM, Salive ME, et al. Cognitive impairment and the risk of stroke in the older population. J Am Geriatr Soc. 1996;44:237-241.
40. White L. Is silent cerebrovascular disease an important cause of late-life cognitive decline? J Am Geriatr Soc. 1996;44:328-329.
41. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
42. Martyn C. Blood pressure and dementia. Lancet 1996;347:1130-1131.
43. Gale CR, Martyn CN, Cooper G. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608-611.
44. Persson G, Skoog I. Subclinical dementia: relevance of cognitive symptoms and signs. J Geriatr Psychiatry Neurol. 1992;5:172-178.
45. Black RS, Bardy LL, Nolan KA, et al. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc. 1992;40:237-244.
46. Villardita C, Grioli S, Lomeo C, et al. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia. Neuropsychobiology. 1992;25:24-28.
47. Cucinotta D, Aveni-Casucci MA, Pedrazzi F, et al. Multicentre clinical placebo- controlled study with buflomedil in the treatment of mild dementia of vascular origin. J Int Med Res. 1992;20:136-149.
48. Parnetti L, Senin U, Carosi M, Baasch H. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. Clin Ther. 1993;15:394-406.
49. Saletu B, Paulus E, Linzmayer L, et al. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology (Berl). 1995;117:385-395.